- Trials with a EudraCT protocol (165)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
165 result(s) found for: Apoptosis.
Displaying page 1 of 9.
EudraCT Number: 2006-006619-64 | Sponsor Protocol Number: 2006SG005 | Start Date*: 2007-07-04 | |||||||||||
Sponsor Name:University Hospital of South Manchester NHS Foundation Trust [...] | |||||||||||||
Full Title: Randomised Controlled Trial of Lapatinib (A Her1/2 Tyrosine Kinase Inhibitor) on Epithelial Proliferation and Apoptosis in Ductal Cancer in Situ. | |||||||||||||
Medical condition: Women with a core biopsy diagnosis of histologically proven Her2 positive DCIS (or DCIS and invasive cancer). Women undergoing re-excision of DCIS will be eligible provided residual DCIS is presen... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005634-12 | Sponsor Protocol Number: EPA/POL/02 | Start Date*: 2006-06-12 |
Sponsor Name:S.L.A. Pharma (UK) Ltd | ||
Full Title: The effect of two dose levels of eicosapentaenoic acid (EPA) on apoptosis and cell proliferation in the colonic mucosa of patients with a history of colonic polyps. | ||
Medical condition: Sporadic colonic adenomata | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000106-37 | Sponsor Protocol Number: 37.07.-92906 | Start Date*: 2008-08-28 | |||||||||||
Sponsor Name:Klinik für Dermatologie und Allergologie der RUB, St. Josef Hospital | |||||||||||||
Full Title: Studies on the combined treatment using etanercept and ultraviolet B for patients with moderate to severe psoriasis vulgaris | |||||||||||||
Medical condition: Psoriasis vulgaris (Plaque-Typ) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006542-34 | Sponsor Protocol Number: PR3076 | Start Date*: 2007-01-08 |
Sponsor Name:Pantarhei Bioscience B.V. | ||
Full Title: Preoperative hormone therapy for pre- and postmenopausal women with ER positive breast cancer: A double blind randomized parallel group phase II trial, comparing the effect of 2 weeks of preoperati... | ||
Medical condition: breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001984-11 | Sponsor Protocol Number: FM-14-B01 | Start Date*: 2014-12-22 | |||||||||||
Sponsor Name:FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E DELLA CURA DEI TUMORI | |||||||||||||
Full Title: “Neo-Adjuvant Treatment with the CDK4,6 inhibitor Palbociclib in HER2-positive and ER-positive breast cancer: effect on Ki67 and apoptosis before, during and after treatment “ | |||||||||||||
Medical condition: Women with a diagnosis of invasive unilateral non metastatic HER2-positive and ER-positive breast cancer suitable for neoadjuvant therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001016-51 | Sponsor Protocol Number: 05-UTROGEL-01 | Start Date*: 2006-02-28 |
Sponsor Name:Karolinska Hospital | ||
Full Title: In vivo effects of transdermal Estradiol+ oral Progesterone vs oral Conjugated Equine Estrogens + MedroxyProgesteroneAcetate on normal human breast cells proliferation: a randomized comparative study | ||
Medical condition: Menopausal symptoms | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019832-11 | Sponsor Protocol Number: EMI114238 | Start Date*: 2010-07-13 |
Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
Full Title: An open-label study to evaluate the utility of the apoptosis imaging biomarker [18F]ML-10 to assess the response to chemotherapy in patients with non Hodgkin's lymphoma. | ||
Medical condition: Non Hodgkin’s lymphoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-004492-21 | Sponsor Protocol Number: CIOCC012008 | Start Date*: 2008-10-07 |
Sponsor Name:Fundación Hospital de Madrid | ||
Full Title: Estudio biológico del efecto de GW572016 (Lapatinib) en la apoptosis celular en el Carcinoma Ductal in Situ en pacientes con cáncer de mama HER2 positivo | ||
Medical condition: Cancer de mama | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001089-33 | Sponsor Protocol Number: 2007-001089-33 | Start Date*: 2008-09-23 | |||||||||||||||||||||
Sponsor Name:University Medical Center Groningen, dept. of Cardiology [...] | |||||||||||||||||||||||
Full Title: Infusion of a single dose of erythropoietin to Prevent Injury in an Ischemia Reperfusion forearm model - A randomised cross-over study to evaluate if infusion of a single dose of EPO protects again... | |||||||||||||||||||||||
Medical condition: Myocardial ischemia-reperfusion injury. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||||||||||||
Trial protocol: NL (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-003122-25 | Sponsor Protocol Number: ICS-1-05 | Start Date*: 2005-11-24 |
Sponsor Name:ANGEL LANAS | ||
Full Title: EFECTO DEL ÁCIDO ACETILSALICÍLICO EN LA PROLIFERACIÓN Y APOPTOSIS CELULAR DEL EPITELIO METAPLÁSICO DEL ESÓFAGO DE BARRETT | ||
Medical condition: Esófago de Barrett. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000908-17 | Sponsor Protocol Number: Siena Eye Cross Linking 2004 | Start Date*: 2007-01-11 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SENESE | |||||||||||||
Full Title: Medical therapy of keratoconus with Riboflavin/Ultraviolet-A collagen Cross-Linking and investigation of the corneal stromal and Keratocytes modifications apoptosis and stromal repopulation with ... | |||||||||||||
Medical condition: Patients affected by keratoconus worsening | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002282-30 | Sponsor Protocol Number: 2014-2 | Start Date*: 2014-07-30 |
Sponsor Name:County council of Ostergotland | ||
Full Title: Effects of oxygen treatment on mechanisms involved in ischemia-reperfusion injury: A pilot study in healthy volunteers. | ||
Medical condition: Study performed in healthy male vonlunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000644-13 | Sponsor Protocol Number: N08AFT | Start Date*: 2008-07-10 |
Sponsor Name:NKI-AVL | ||
Full Title: A randomized, prospective trial of 2-6 weeks pre-operative hormonal treatment for hormone receptor positive breast cancer: Anastrozole +/- Fulvestrant or Tamoxifen Exposure - response in molecular ... | ||
Medical condition: Invasive Breast Cancer, tumor size >= 1 cm (NOT inflammatory breast cancer), no clues of metastatic disease, no multicentric breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000707-34 | Sponsor Protocol Number: 2316 | Start Date*: 2011-11-08 |
Sponsor Name:The Newcastle upon Tyne Hospitals NHS Trust | ||
Full Title: The induction of apoptosis by anti-psoriatic treatments | ||
Medical condition: Psoriasis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002485-11 | Sponsor Protocol Number: EGF104334 | Start Date*: 2006-02-03 |
Sponsor Name:GlaxoSmithKline Research & Development Ltd. | ||
Full Title: A Randomized, Single Blind, Placebo-controlled, Multi-centre, Phase II Study of Lapatinib in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck | ||
Medical condition: Sqamous Cell Carcinoma of the Head & Neck (SCCHN) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) ES (Completed) GR (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001743-20 | Sponsor Protocol Number: 1403-MAD-013-AR | Start Date*: 2015-07-30 |
Sponsor Name:IVI Madrid | ||
Full Title: A Multicentre, prospective, randomised clinical trial comparing the cost and efficacy of corifolitropina alfa vs Recombinant FSH and / or HP-hMG | ||
Medical condition: The study is proposed to determine the level of compliance and pharmacoeconomic impact of three protocols for controlled ovarian stimulation in women participating in oocyte donation program | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004970-24 | Sponsor Protocol Number: 2012-004970-24 | Start Date*: 2013-04-19 | |||||||||||
Sponsor Name:Fundació Clinic per a la Recerca Biomèdica | |||||||||||||
Full Title: Virological and immunological safety of a dose reduction strategy antiretroviral regimen with efavirenz / tenofovir / emtricitabine | |||||||||||||
Medical condition: HIV -1 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002214-77 | Sponsor Protocol Number: 1504-MAD-024-AR | Start Date*: 2016-05-05 |
Sponsor Name:IVI Madrid | ||
Full Title: Prospective randomized clinical trial to test the efficacy of a biosimilar recombinant FSH (Bemfola) vs. urinary FSH (Fostipur) in an oocyte donation program | ||
Medical condition: The proposed study is to determine the efficacy of a recombinant FSH biosimilar vs. urinary FSH in oocyte donation program | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001179-13 | Sponsor Protocol Number: 16891 | Start Date*: 2008-01-24 | |||||||||||
Sponsor Name:Dutch Cancer Society | |||||||||||||
Full Title: Neo-adjuvant Simvastatin therapy in colorectal cancer | |||||||||||||
Medical condition: Colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006782-83 | Sponsor Protocol Number: EC08/00230 | Start Date*: 2013-09-24 |
Sponsor Name:Hospital Universitario Virgen de las Nieves | ||
Full Title: Prevention MODS by modulating the inflammatory response through melatonin administration in surgical patients with severe sepsis. | ||
Medical condition: Septic patients of abdominal surgery | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.